Loading...
Towards the sustainable discovery and development of new antibiotics.
Miethke, Marcus Pieroni, Marco Weber, Tilmann Hammann, Peter Halby, Ludovic Arimondo, Paola B Glaser, Philippe Aigle, Bertrand Bode, Helge B
Miethke, Marcus
Pieroni, Marco
Weber, Tilmann
Hammann, Peter
Halby, Ludovic
Arimondo, Paola B
Glaser, Philippe
Aigle, Bertrand
Bode, Helge B
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2021-08-19
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 2.44 MB
Other Titles
Abstract
An ever-increasing demand for novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark contrast to the current level of investment in their development, particularly in the fields of natural-product-derived and synthetic small molecules. New agents displaying innovative chemistry and modes of action are desperately needed worldwide to tackle the public health menace posed by antimicrobial resistance. Here, our consortium presents a strategic blueprint to substantially improve our ability to discover and develop new antibiotics. We propose both short-term and long-term solutions to overcome the most urgent limitations in the various sectors of research and funding, aiming to bridge the gap between academic, industrial and political stakeholders, and to unite interdisciplinary expertise in order to efficiently fuel the translational pipeline for the benefit of future generations.
Citation
Nat Rev Chem. 2021 Aug 19:1-24. doi: 10.1038/s41570-021-00313-1. Epub ahead of print.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Review
Language
en
Description
Series/Report no.
ISSN
2397-3358
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International